TYRA Stock Analysis: Buy, Sell, or Hold?
TYRA - Tyra Biosciences, Inc. Common Stock
$39.37
1.09 (2.85%)
▲
5d:
+3.52%
30d:
+11.62%
90d:
+49.75%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Distribution
TYRA is up 5.5% this week, but smart money is buying puts. Top strike: $35 2026-05-15 with 6 OI. Put ratio: 100% View Scanner →
Strength: 7.7/10
Get Alerted When TYRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TYRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TYRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TYRA is currently trading at $39.37, which is considered extended relative to its 30-day fair value range of $33.57 to $37.28.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $34.01, while resistance sits at $40.65.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.07 (+33.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TYRA is in a strong uptrend. Immediate support is located at $34.01, while resistance sits at $40.65.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $51.07 (+33.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$33.57 -
$37.28
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price extended above range (+5.6% above fair value)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.4% below Wall St target ($51.07)
Fair Price Analysis
30-Day Fair Range
$33.57 -
$37.28
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$34.01
Resistance Level
$40.65
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.42
Wall Street Target
$51.07
(+33.4%)
Share & Embed Analysis
Last updated: April 02, 2026 3:25 PM ET
Data refreshes hourly during market hours. Next update: 4:25 PM
Data refreshes hourly during market hours. Next update: 4:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TYRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert J More
SELL
10000 shares
2025-12-19
Robert J More
SELL
246871 shares
2025-11-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 53 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$33 | 61 BUY |
